SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-035138
Filing Date
2023-12-21
Accepted
2023-12-21 17:14:47
Documents
13
Period of Report
2023-12-15
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tlry20231221_8k.htm   iXBRL 8-K 22797
  Complete submission text file 0001437749-23-035138.txt   153370

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlry-20231215.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlry-20231215_def.xml EX-101.DEF 11425
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20231215_lab.xml EX-101.LAB 15311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20231215_pre.xml EX-101.PRE 11585
7 EXTRACTED XBRL INSTANCE DOCUMENT tlry20231221_8k_htm.xml XML 2553
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 231506161
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)